Clinical Trials
4
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)Study of ORL-1M (D-mannose) in Patients With CDG-Ib
Phase 1
- Conditions
- CDG Ib
- Interventions
- Drug: ORL-1M - D-mannose
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2019-01-25
- Lead Sponsor
- Orpha Labs
- Target Recruit Count
- 5
- Registration Number
- NCT03404869
- Locations
- 🇹🇷
Orpha Labs, Ankara, Turkey
Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14
Phase 1
- Conditions
- Glycogen Storage Disease, Type 14
- Interventions
- Drug: ORL-1G - D-galactose
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2019-01-25
- Lead Sponsor
- Orpha Labs
- Target Recruit Count
- 5
- Registration Number
- NCT03404856
- Locations
- 🇹🇷
Orpha Labs, Ankara, Turkey
Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II
- First Posted Date
- 2017-11-28
- Last Posted Date
- 2019-01-25
- Lead Sponsor
- Orpha Labs
- Target Recruit Count
- 4
- Registration Number
- NCT03354533
Study of ORL-1B in Patients With Biotinidase Deficiency
- First Posted Date
- 2017-08-31
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Orpha Labs
- Target Recruit Count
- 20
- Registration Number
- NCT03269045
News
No news found